Tonix Pharmaceuticals Holding (TNXP) Invested Capital (2023 - 2025)
Historic Invested Capital for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $231.1 million.
- Tonix Pharmaceuticals Holding's Invested Capital rose 18625.94% to $231.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.1 million, marking a year-over-year increase of 18625.94%. This contributed to the annual value of $148.2 million for FY2024, which is 2718.99% up from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its Invested Capital stood at $231.1 million for Q3 2025, which was up 18625.94% from $168.0 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Invested Capital registered a high of $231.1 million during Q3 2025, and its lowest value of $49.3 million during Q2 2024.
- In the last 3 years, Tonix Pharmaceuticals Holding's Invested Capital had a median value of $140.5 million in 2023 and averaged $137.9 million.
- Its Invested Capital has fluctuated over the past 5 years, first plummeted by 6487.12% in 2024, then soared by 24047.59% in 2025.
- Tonix Pharmaceuticals Holding's Invested Capital (Quarter) stood at $116.5 million in 2023, then grew by 27.19% to $148.2 million in 2024, then skyrocketed by 55.96% to $231.1 million in 2025.
- Its Invested Capital stands at $231.1 million for Q3 2025, versus $168.0 million for Q2 2025 and $180.4 million for Q1 2025.